Parnes; Jason

Patent Applications and Registrations

Patent applications and USPTO patent grants for Parnes; Jason.The latest application filed is for "pyrazino[2,3-b]pyrazine mtor kinase inhibitors for oncology indications and diseases associated with the mtor/pi3k/akt pathway".

Company Profile

5.14.13

Parnes; Jason - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Grant 11,292,796 - Elsner , et al. April 5, 2	2022-04-05
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20200262840 - ELSNER; Jan ; et al.	2020-08-20
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Grant 10,683,298 - Elsner , et al.	2020-06-16
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20190077806 - ELSNER; Jan ; et al.	2019-03-14
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Grant 10,167,290 - Elsner , et al. J	2019-01-01
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20170342080 - ELSNER; Jan ; et al.	2017-11-30
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith Grant 9,783,505 - Papa , et al. October 10, 2	2017-10-10
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Grant 9,771,371 - Elsner , et al. September 26, 2	2017-09-26
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith Grant 9,556,126 - Papa , et al. January 31, 2	2017-01-31
Substituted Diaminopyrimidyl Compounds, Compositions Thereof, And Methods Of Treatment Therewith App 20160354374 - Papa; Patrick ; et al.	2016-12-08
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20160024101 - ELSNER; Jan ; et al.	2016-01-28
Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors Grant 9,193,692 - Perrin-Ninkovic , et al. November 24, 2	2015-11-24
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith Grant 9,156,798 - Bahmanyar , et al. October 13, 2	2015-10-13
Substituted Diaminopyrimidyl Compounds, Compositions Thereof, And Methods Of Treatment Therewith App 20150246890 - BAHMANYAR; Sogole ; et al.	2015-09-03
Substituted Diaminopyrimidyl Compounds, Compositions Thereof, And Methods Of Treatment Therewith App 20150175557 - Papa; Patrick ; et al.	2015-06-25
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20150051397 - Perrin-Ninkovic; Sophie ; et al.	2015-02-19
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Grant 8,907,087 - Perrin-Ninkovic , et al. December 9, 2	2014-12-09
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20130289271 - Perrin-Ninkovic; Sophie ; et al.	2013-10-31
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Grant 8,507,492 - Perrin-Ninkovic , et al. August 13, 2	2013-08-13
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Grant 8,492,381 - Perrin-Ninkovic , et al. July 23, 2	2013-07-23
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20120071658 - Perrin-Ninkovic; Sophie ; et al.	2012-03-22
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20120059164 - Perrin-Ninkovic; Sophie ; et al.	2012-03-08
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Grant 8,110,578 - Perrin-Ninkovic , et al. February 7, 2	2012-02-07
mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY App 20100216781 - Perrin-Ninkovic; Sophie ; et al.	2010-08-26
Pyrazole Pyrazine Amine Compounds As Kinase Inhibitors, Compositions Thereof And Methods Of Treatment Therewith App 20090270418 - Sloss; Marianne ; et al.	2009-10-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.